These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 39142152

  • 1. Oral formulations for highly lipophilic drugs: Impact of surface decoration on the efficacy of self-emulsifying drug delivery systems.
    Sandmeier M, Hoeng J, Skov Jensen S, Nykjær Nikolajsen G, Ziegler Bruun H, To D, Ricci F, Schifferle M, Bernkop-Schnürch A.
    J Colloid Interface Sci; 2025 Jan; 677(Pt A):1108-1119. PubMed ID: 39142152
    [Abstract] [Full Text] [Related]

  • 2. Cellular uptake of self-emulsifying drug-delivery systems: polyethylene glycol versus polyglycerol surface.
    Friedl JD, Steinbring C, Zaichik S, Le NN, Bernkop-Schnürch A.
    Nanomedicine (Lond); 2020 Aug; 15(19):1829-1841. PubMed ID: 32781886
    [Abstract] [Full Text] [Related]

  • 3. Replacing PEG-surfactants in self-emulsifying drug delivery systems: Surfactants with polyhydroxy head groups for advanced cytosolic drug delivery.
    Friedl JD, Jörgensen AM, Nguyen Le NM, Steinbring C, Bernkop-Schnürch A.
    Int J Pharm; 2022 Apr 25; 618():121633. PubMed ID: 35304244
    [Abstract] [Full Text] [Related]

  • 4. Comparative Analysis of PEG-Free and PEG-Based Self-Emulsifying Drug Delivery Systems for Enhanced Oral Bioavailability of Therapeutic (Poly) Peptides.
    Haddadzadegan S, To D, Matteo Jörgensen A, Wibel R, Laffleur F, Bernkop-Schnürch A.
    Small; 2024 Jul 25; 20(27):e2307618. PubMed ID: 38308358
    [Abstract] [Full Text] [Related]

  • 5. Phosphorylated PEG-emulsifier: Powerful tool for development of zeta potential changing self-emulsifying drug delivery systems (SEDDS).
    Wolf JD, Kurpiers M, Götz RX, Zaichik S, Hupfauf A, Baecker D, Gust R, Bernkop-Schnürch A.
    Eur J Pharm Biopharm; 2020 May 25; 150():77-86. PubMed ID: 32151729
    [Abstract] [Full Text] [Related]

  • 6. Combination of SEDDS and Preactivated Thiomer Technology: Incorporation of a Preactivated Thiolated Amphiphilic Polymer into Self-Emulsifying Delivery Systems.
    Hetényi G, Griesser J, Nardin I, Bernkop-Schnürch A.
    Pharm Res; 2017 Jun 25; 34(6):1171-1179. PubMed ID: 28283859
    [Abstract] [Full Text] [Related]

  • 7. Self-emulsifying drug delivery systems: Design of a novel vaginal delivery system for curcumin.
    Köllner S, Nardin I, Markt R, Griesser J, Prüfert F, Bernkop-Schnürch A.
    Eur J Pharm Biopharm; 2017 Jun 25; 115():268-275. PubMed ID: 28323109
    [Abstract] [Full Text] [Related]

  • 8. Formulation Development and Evaluation of Cannabidiol Hot-Melt Extruded Solid Self-Emulsifying Drug Delivery System for Oral Applications.
    Sanil K, Almotairy A, Uttreja P, Ashour EA.
    AAPS PharmSciTech; 2024 Jun 11; 25(5):136. PubMed ID: 38862810
    [Abstract] [Full Text] [Related]

  • 9. PEG vs. zwitterions: How these surface decorations determine cellular uptake of lipid-based nanocarriers.
    Stengel D, Demirel BH, Knoll P, Truszkowska M, Laffleur F, Bernkop-Schnürch A.
    J Colloid Interface Sci; 2023 Oct 11; 647():52-64. PubMed ID: 37244176
    [Abstract] [Full Text] [Related]

  • 10. Oral drug delivery: Influence of mucus on cellular interactions and uptake of lipid-based nanocarriers in Caco-2 cells.
    Veider F, Knoll P, Jörgensen AM, Stengel D, Bernkop-Schnürch A.
    Acta Biomater; 2023 Sep 01; 167():416-424. PubMed ID: 37311506
    [Abstract] [Full Text] [Related]

  • 11. Development and in vitro characterization of a papain loaded mucolytic self-emulsifying drug delivery system (SEDDS).
    Leichner C, Menzel C, Laffleur F, Bernkop-Schnürch A.
    Int J Pharm; 2017 Sep 15; 530(1-2):346-353. PubMed ID: 28782582
    [Abstract] [Full Text] [Related]

  • 12. Zeta potential changing self-emulsifying drug delivery systems: A promising strategy to sequentially overcome mucus and epithelial barrier.
    Nazir I, Fürst A, Lupo N, Hupfauf A, Gust R, Bernkop-Schnürch A.
    Eur J Pharm Biopharm; 2019 Nov 15; 144():40-49. PubMed ID: 31505225
    [Abstract] [Full Text] [Related]

  • 13. Development and in vitro characterization of self-emulsifying drug delivery system (SEDDS) for oral opioid peptide delivery.
    Zupančič O, Rohrer J, Thanh Lam H, Grießinger JA, Bernkop-Schnürch A.
    Drug Dev Ind Pharm; 2017 Oct 15; 43(10):1694-1702. PubMed ID: 28589736
    [Abstract] [Full Text] [Related]

  • 14. Development and in vitro evaluation of zeta potential changing self-emulsifying drug delivery systems for enhanced mucus permeation.
    Suchaoin W, Pereira de Sousa I, Netsomboon K, Lam HT, Laffleur F, Bernkop-Schnürch A.
    Int J Pharm; 2016 Aug 20; 510(1):255-62. PubMed ID: 27329673
    [Abstract] [Full Text] [Related]

  • 15. Development and in vitro characterization of an oral self-emulsifying delivery system (SEDDS) for rutin fatty ester with high mucus permeating properties.
    Cardona MI, Nguyen Le NM, Zaichik S, Aragón DM, Bernkop-Schnürch A.
    Int J Pharm; 2019 May 01; 562():180-186. PubMed ID: 30898639
    [Abstract] [Full Text] [Related]

  • 16. Trypsin decorated self-emulsifying drug delivery systems (SEDDS): Key to enhanced mucus permeation.
    Shahzadi I, Dizdarević A, Efiana NA, Matuszczak B, Bernkop-Schnürch A.
    J Colloid Interface Sci; 2018 Dec 01; 531():253-260. PubMed ID: 30036849
    [Abstract] [Full Text] [Related]

  • 17. Development, in vitro and in vivo evaluation of a self-emulsifying drug delivery system (SEDDS) for oral enoxaparin administration.
    Zupančič O, Grieβinger JA, Rohrer J, Pereira de Sousa I, Danninger L, Partenhauser A, Sündermann NE, Laffleur F, Bernkop-Schnürch A.
    Eur J Pharm Biopharm; 2016 Dec 01; 109():113-121. PubMed ID: 27693677
    [Abstract] [Full Text] [Related]

  • 18. Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers.
    Haddadzadegan S, Dorkoosh F, Bernkop-Schnürch A.
    Adv Drug Deliv Rev; 2022 Mar 01; 182():114097. PubMed ID: 34999121
    [Abstract] [Full Text] [Related]

  • 19. Role of solid carriers in pharmaceutical performance of solid supersaturable SEDDS of celecoxib.
    Chavan RB, Modi SR, Bansal AK.
    Int J Pharm; 2015 Nov 10; 495(1):374-384. PubMed ID: 26364711
    [Abstract] [Full Text] [Related]

  • 20. Highly mucus permeating and zeta potential changing self-emulsifying drug delivery systems: A potent gene delivery model for causal treatment of cystic fibrosis.
    Griesser J, Hetényi G, Federer C, Steinbring C, Ellemunter H, Niedermayr K, Bernkop-Schnürch A.
    Int J Pharm; 2019 Feb 25; 557():124-134. PubMed ID: 30594687
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.